| Literature DB >> 35296694 |
Antonio Ciardo1, Marlinde M Simon2, Sarah K Sonnenschein2, Christopher Büsch3, Ti-Sun Kim2.
Abstract
The objective of this study was to investigate oral health-related quality of life (OHRQoL) in times of the COVID-19 pandemic and to examine a possible association to psychosocial factors like psychological stress and symptoms of depression and anxiety disorders. Secondary research questions were whether people changed oral hygiene regimens during the COVID-19 pandemic and to what extent dental symptoms existed and developed compared to pre-pandemic. For this cross-sectional study a survey has been conceptualized to determine OHRQoL, stress, depression and anxiety and their specific confounders in a German cohort. Validated questionnaires as OHIP-G14, PHQ-Stress and PHQ-4 have been implemented. Altogether 1178 participants completed the survey between May and August 2020. The overall OHIP-G14 sum score of 4.8 ± 7.5 indicated good OHRQoL. 21% of the participants (n = 248) reported toothache, 23% (n = 270) mucosal problems, 31% (n = 356) hypersensitivity of the teeth and 27% (n = 305) myofacial pain. The PHQ-Stress score (4.5 ± 3.5) demonstrated a mild severity of stress. Depression and anxiety level has been mild to moderate (PHQ-4 score: 2.4 ± 2.6). 38% of the participants stated subjectively greater emotional burden compared to pre-pandemic. Statistically significant differences exist for OHRQoL, stress, anxiety and depression levels between participants with greater, equal or less emotional burden compared to pre-pandemic. COVID-19 history and aggravated levels of depression, anxiety, and stress seem to associate with lower OHRQoL. Psychosocial consequences during pandemic times and their association to oral health should be further investigated.Entities:
Mesh:
Year: 2022 PMID: 35296694 PMCID: PMC8924572 DOI: 10.1038/s41598-022-07907-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and general data of the study cohort.
| Variables | Total (n = 1178) | Greater emotional burden compared to pre-pandemic (n = 429) | Equal emotional burden compared to pre-pandemic (n = 594) | Less emotional burden compared to pre-pandemic (n = 134) | Emotional burden compared to pre-pandemic data missing (n = 21) |
|---|---|---|---|---|---|
| 18–29 years | 215 (18%) | 83 (19%) | 99 (17%) | 30 (22%) | 3 (17%) |
| 30–39 years | 192 (16%) | 83 (19%) | 86 (15%) | 19 (14%) | 4 (22%) |
| 40–49 years | 129 (11%) | 57 (13%) | 57 (10%) | 14 (10%) | 1 (6%) |
| 50–59 years | 236 (20%) | 109 (25%) | 109 (18%) | 18 (13%) | 0 (0%) |
| 60–69 years | 194 (17%) | 64 (15%) | 106 (18%) | 21 (16%) | 3 (17%) |
| 70–79 years | 134 (11%) | 18 (4%) | 94 (16%) | 21 (16%) | 1 (6%) |
| 80–89 years | 67 (6%) | 13 (3%) | 39 (7%) | 10 (7%) | 5 (28%) |
| 90–99 years | 3 (0%) | 0 (0%) | 2 (0%) | 1 (1%) | 0 (0%) |
| ≥ 100 years | 2 (0%) | 1 (0%) | 0 (0%) | 0 (0%) | 1 (6%) |
| Missing | 6 | 1 | 2 | 0 | 3 |
| Male | 426 (36%) | 106 (25%) | 251 (42%) | 58 (44%) | 11 (58%) |
| Female | 747 (64%) | 322 (75%) | 342 (58%) | 75 (56%) | 8 (42%) |
| Missing | 5 | 1 | 1 | 1 | 2 |
| Never smoker | 623 (53%) | 221 (52%) | 322 (54%) | 66 (50%) | 14 (74%) |
| Former smoker | 363 (31%) | 130 (30%) | 190 (32%) | 39 (29%) | 4 (21%) |
| Active smoker, < 10 cigarettes per day | 84 (7%) | 38 (9%) | 35 (6%) | 11 (8%) | 0 (0%) |
| Active smoker, ≥ 10 cigarettes per day | 104 (9%) | 40 (9%) | 46 (8%) | 17 (13%) | 1 (5%) |
| Missing | 4 | 0 | 1 | 1 | 2 |
| n (missing) | 1132 (46; 4%) | 416 (13; 3%) | 577 (17; 3%) | 128 (6; 4%) | 11 (10; 48%) |
| BMI ± SD | 25.0 ± 4.8 | 25.0 ± 5.3 | 25.0 ± 4.5 | 25.0 ± 4.6 | 25.0 ± 3.3 |
| ≤ 10 years of school | 352 (30%) | 118 (28%) | 183 (31%) | 40 (31%) | 11 (61%) |
| > 10 years of school | 817 (70%) | 311 (72%) | 408 (69%) | 91 (69%) | 7 (39%) |
| Missing | 9 | 0 | 3 | 3 | 3 |
| Employed | 538 (47%) | 228 (54%) | 261 (44%) | 47 (36%) | 2 (18%) |
| Self-employed | 138 (12%) | 68 (16%) | 55 (9%) | 15 (11%) | 0 (0%) |
| Unemployed | 33 (3%) | 11 (3%) | 15 (3%) | 7 (5%) | 0 (0%) |
| Student/In Training | 126 (11%) | 50 (12%) | 58 (10%) | 18 (14%) | 0 (0%) |
| Retired | 320 (28%) | 66 (16%) | 200 (34%) | 45 (34%) | 9 (82%) |
| Missing | 23 | 6 | 5 | 2 | 10 |
| Lung disease (COPD, Asthma, etc.) | 93 (8%) | 46 (11%) | 37 (6%) | 10 (7%) | 0 (0%) |
| Cardiovascular disease | 161 (14%) | 54 (13%) | 87 (15%) | 17 (13%) | 3 (1%) |
| Diabetes mellitus | 63 (5%) | 19 (44%) | 29 (5%) | 12 (9%) | 3 (1%) |
| Other systemic diseases | 215 (18%) | 92 (21%) | 96 (16%) | 26 (19%) | 1 (0%) |
| No systemic diseases | 698 (59%) | 243 (57%) | 373 (63%) | 78 (58%) | 4 (2%) |
| Baden-Württemberg | 488 (44%) | 153 (37%) | 263 (47%) | 66 (54%) | 6 (60%) |
| Bavaria | 55 (5%) | 33 (8%) | 17 (3%) | 5 (4%) | 0 (0%) |
| Berlin | 16 (1%) | 8 (2%) | 7 (1%) | 1 (1%) | 0 (0%) |
| Brandenburg | 3 (0%) | 2 (0%) | 1 (0%) | 0 (0%) | 0 (0%) |
| Bremen | 1 (0%) | 1 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Hamburg | 4 (0%) | 2 (0%) | 2 (0%) | 0 (0%) | 0 (0%) |
| Hesse | 271 (25%) | 84 (20%) | 155 (28%) | 29 (24%) | 3 (30%) |
| Mecklenburg-Vorpommern | 2 (0%) | 1 (0%) | 1 (0%) | 0 (0%) | 0 (0%) |
| Lower Saxony | 41 (4%) | 26 (6%) | 14 (2%) | 1 (1%) | 0 (0%) |
| North Rhine-Westphalia | 105 (10%) | 49 (12%) | 47 (8%) | 9 (7%) | 0 (0%) |
| Rhineland-Palatinate | 83 (8%) | 33 (8%) | 41 (7%) | 8 (7%) | 1 (10%) |
| Saarland | 3 (0%) | 3 (1%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Saxony | 10 (1%) | 6 (1%) | 4 (1%) | 0 (0%) | 0 (0%) |
| Saxony-Anhalt | 5 (0%) | 3 (1%) | 2 (0%) | 0 (0%) | 0 (0%) |
| Schleswig–Holstein | 2 (0%) | 1 (0%) | 1 (0%) | 0 (0%) | 0 (0%) |
| Thuringia | 16 (1%) | 8 (2%) | 5 (1%) | 3 (2%) | 0 (0%) |
| Missing | 73 | 16 | 34 | 12 | 11 |
| No COVID-19 history | 1136 (98%) | 418 (98%) | 583 (98%) | 130 (99%) | 5 (100%) |
| Confirmed COVID-19 history without hospitalization | 14 (1%) | 4 (1%) | 9 (2%) | 1 (1%) | 0 (0%) |
| Confirmed COVID-19 history and hospitalization | 5 (0%) | 5 (1%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Missing | 23 | 2 | 2 | 3 | 16 |
| Strong restrictions | 295 (26%) | 192 (45%) | 83 (14%) | 18 (14%) | 2 (18%) |
| Little restrictions | 710 (62%) | 218 (51%) | 401 (68%) | 84 (65%) | 7 (64%) |
| No restrictions | 146 (13%) | 14 (3%) | 102 (17%) | 28 (22%) | 2 (18%) |
| Missing | 27 | 5 | 8 | 4 | 10 |
| Strong influence | 431 (41%) | 238 (59%) | 153 (29%) | 40 (34%) | 0 (0%) |
| Little influence | 319 (30%) | 105 (26%) | 179 (34%) | 34 (29%) | 1 (17%) |
| No influence | 308 (29%) | 59 (15%) | 200 (38%) | 44 (37%) | 5 (83%) |
| Missing | 120 | 27 | 62 | 16 | 15 |
| Strong influence | 519 (46%) | 291 (69%) | 185 (32%) | 42 (33%) | 1 (12%) |
| Little influence | 494 (43%) | 122 (29%) | 306 (53%) | 60 (47%) | 6 (75%) |
| No influence | 125 (11%) | 8 (2%) | 91 (16%) | 25 (20%) | 1 (12%) |
| Missing | 40 | 8 | 12 | 7 | 13 |
n number of participants, COVID-19 coronavirus disease 2019, SD standard deviation.
Oral health-related parameters.
| Variables | Total (n = 1178) | Greater emotional burden compared to pre-pandemic (n = 429) | Equal emotional burden compared to pre-pandemic (n = 594) | Less emotional burden compared to pre-pandemic (n = 134) | Emotional burden compared to pre-pandemic data missing (n = 21) | p-Value |
|---|---|---|---|---|---|---|
| No | 787 (67%) | 271 (63%) | 410 (69%) | 92 (70%) | 14 (74%) | |
| Sometimes | 357 (30%) | 143 (33%) | 171 (29%) | 38 (29%) | 5 (26%) | |
| Often | 27 (2%) | 14 (3%) | 11 (2%) | 2 (2%) | 0 (0%) | |
| Missing | 7 | 1 | 2 | 2 | 2 | |
| No | 1052 (91%) | 382 (91%) | 539 (91%) | 115 (88%) | 16 (84%) | |
| Yes | 110 (9%) | 40 (9%) | 52 (9%) | 15 (12%) | 3 (16%) | |
| Missing | 16 | 7 | 3 | 4 | 2 | |
| n | 1149 | 421 | 587 | 124 | 17 | |
| Missing | 29 (2%) | 8 (2%) | 7 (1%) | 10 (7%) | 4 (19%) | |
| Mean | 6.9 | 6.2 | 7.4 | 7.1 | 8.2 | |
| SD | 4.0 | 3.6 | 4.1 | 4.3 | 5.0 | |
| Median | 7 | 6 | 8 | 8 | 9 | |
| Q1–Q3 | 3–10 | 3–9 | 4–11 | 3–11 | 4–12 | |
| Min–Max | 0–17 | 0–16 | 0–17 | 0–15 | 2–16 | |
| Yes, treated | 361 (31%) | 109 (26%) | 199 (34%) | 49 (37%) | 4 (21%) | |
| Yes, not treated | 26 (2%) | 9 (2%) | 14 (2%) | 3 (2%) | 0 (0%) | |
| No | 659 (56%) | 256 (61%) | 324 (55%) | 66 (50%) | 10 (53%) | |
| Unknown | 122 (10%) | 48 (11%) | 55 (9%) | 14 (11%) | 5 (26%) | |
| Missing | 10 | 4 | 2 | 2 | 2 | |
| I have natural teeth | 1031 (88%) | 386 (90%) | 516 (87%) | 116 (87%) | 13 (62%) | |
| I am edentulous | 11 (1%) | 3 (1%) | 6 (1%) | 1 (1%) | 1 (5%) | |
| I have implants | 264 (22%) | 92 (21%) | 140 (24%) | 27 (20%) | 5 (24%) | |
| I wear dentures | 113 (10%) | 32 (7%) | 61 (10%) | 17 (13%) | 3 (14%) | |
| 0.671chi2 | ||||||
| 2/year | 658 (56%) | 252 (59%) | 322 (54%) | 77 (58%) | 7 (39%) | |
| 1/year | 380 (32%) | 128 (30%) | 201 (34%) | 42 (32%) | 9 (50%) | |
| < 1/year | 133 (11%) | 48 (11%) | 69 (12%) | 14 (11%) | 2 (11%) | |
| Missing | 7 | 1 | 2 | 1 | 3 | |
| 0.270chi2 | ||||||
| ≥ 2/day | 899 (77%) | 333 (78%) | 456 (77%) | 96 (72%) | 14 (78%) | |
| 1/day | 257 (22%) | 92 (21%) | 128 (22%) | 33 (25%) | 4 (22%) | |
| < 1/day | 15 (1%) | 3 (1%) | 8 (1%) | 4 (3%) | 0 (0%) | |
| Missing | 7 | 1 | 2 | 1 | 3 | |
| Yes, with interdental brushes | 512 (44%) | 165 (39%) | 282 (48%) | 56 (42%) | 9 (50%) | |
| Yes, with dental floss | 317 (27%) | 136 (32%) | 143 (24%) | 34 (26%) | 4 (22%) | |
| Yes, with other tools | 82 (7%) | 26 (6%) | 41 (7%) | 14 (11%) | 1 (6%) | |
| No | 259 (22%) | 101 (24%) | 126 (21%) | 28 (21%) | 4 (22%) | |
| Missing | 8 | 1 | 2 | 2 | 3 | |
| Less often | 34 (3%) | 23 (5%) | 7 (1%) | 3 (2%) | 1 (6%) | |
| Unchanged | 1083 (93%) | 384 (90%) | 562 (95%) | 121 (91%) | 16 (94%) | |
| More often | 53 (5%) | 20 (5%) | 24 (4%) | 9 (7%) | 0 (0%) | |
| Missing | 8 | 2 | 1 | 1 | 4 | |
| Worse than pre-pandemic | 46 (4%) | 25 (6%) | 17 (3%) | 4 (3%) | 0 (0%) | |
| Equivalent to pre-pandemic | 200 (17%) | 90 (21%) | 93 (16%) | 17 (13%) | 0 (0%) | |
| Better than pre-pandemic | 2 (0%) | 0 (0%) | 1 (0%) | 1 (1%) | 0 (0%) | |
| None | 904 (78%) | 308 (73%) | 479 (81%) | 111 (83%) | 6 (100%) | |
| Missing | 26 | 6 | 4 | 1 | 15 | |
| Worse than pre-pandemic | 55 (5%) | 30 (7%) | 20 (3%) | 5 (4%) | 0 (0%) | |
| Equivalent to pre-pandemic | 212 (18%) | 89 (21%) | 104 (18%) | 19 (14%) | 0 (0%) | |
| Better than pre-pandemic | 3 (0%) | 2 (0%) | 1 (0%) | 0 (0%) | 0 (0%) | |
| None | 882 (77%) | 302 (71%) | 464 (79%) | 110 (82%) | 6 (100%) | |
| Missing | 26 | 6 | 5 | 0 | 15 | |
| Worse than pre-pandemic | 58 (5%) | 38 (9%) | 15 (3%) | 5 (4%) | 0 (0%) | |
| Equivalent to pre-pandemic | 291 (25%) | 120 (29%) | 148 (25%) | 23 (17%) | 0 (0%) | |
| Better than pre-pandemic | 7 (1%) | 2 (0%) | 4 (1%) | 1 (1%) | 0 (0%) | |
| None | 796 (69%) | 261 (62%) | 424 (72%) | 105 (78%) | 6 (100%) | |
| Missing | 26 | 8 | 3 | 0 | 15 | |
| Worse than pre-pandemic | 75 (7%) | 55 (13%) | 17 (3%) | 3 (2%) | 0 (0%) | |
| Equivalent to pre-pandemic | 223 (19%) | 89 (21%) | 110 (19%) | 24 (18%) | 0 (0%) | |
| Better than pre-pandemic | 7 (1%) | 2 (0%) | 2 (0%) | 3 (2%) | 0 (0%) | |
| None | 846 (74%) | 276 (65%) | 460 (78%) | 104 (78%) | 6 (100%) | |
| Missing | 27 | 7 | 5 | 0 | 15 | |
Significant values are in bold.
All missing values were excluded for statistical testing.
n number of participants, COVID-19 coronavirus disease 2019, SD standard deviation, Q Quartile, Min Minimum, Max Maximum, MWU Mann–Whitney U test, chi2 chi-squared test, KW Kruskal–Wallis one-way ANOVA.
Psychosocial factors.
| Variables | Total (n = 1178) | Greater emotional burden compared to pre-pandemic (n = 429) | Equal emotional burden compared to pre-pandemic (n = 594) | Less emotional burden compared to pre-pandemic (n = 134) | Emotional burden compared to pre-pandemic data missing (n = 21) | p-Value |
|---|---|---|---|---|---|---|
| n | 1043 | 395 | 530 | 115 | 3 | |
| Missing | 135 (11%) | 34 (8%) | 64 (11%) | 19 (14%) | 18 (86%) | |
| Mean | 4.5 | 6.6 | 3.2 | 3.4 | 2.7 | |
| SD | 3.5 | 3.4 | 2.7 | 3.1 | 3.8 | |
| Median | 4 | 6 | 3 | 3 | 1 | |
| Q1–Q3 | 2–7 | 4–9 | 1–5 | 1–4 | 0–7 | |
| Min–Max | 0–20 | 0–19 | 0–13 | 0–20 | 0–7 | |
| n | 1141 | 420 | 584 | 129 | 8 | |
| Missing | 37 (3%) | 9 (2%) | 10 (2%) | 5 (4%) | 13 (62%) | |
| Mean | 2.4 | 4 | 1.4 | 1.4 | 1.8 | |
| SD | 2.6 | 2.8 | 1.7 | 1.8 | 2.5 | |
| Median | 2 | 4 | 1 | 1 | 0.5 | |
| Q1–Q3 | 0–4 | 2–5 | 0–2 | 0–2 | 0–3 | |
| Min–Max | 0–12 | 0–12 | 0–12 | 0–12 | 0–7 | |
| Much greater | 64 (6%) | 64 (15%) | 0 (0%) | 0 (0%) | ||
| Greater | 365 (32%) | 365 (85%) | 0 (0%) | 0 (0%) | ||
| Equal | 594 (51%) | 0 (0%) | 594 (100%) | 0 (0%) | ||
| Less | 100 (9%) | 0 (0%) | 0 (0%) | 100 (75%) | ||
| Much less | 34 (3%) | 0 (0%) | 0 (0%) | 34 (25%) | ||
| Missing | 21 | 0 | 0 | 0 | 21 | |
Significant values are in bold.
All missing values were excluded for statistical testing.
n number of participants, COVID-19 coronavirus disease 2019, SD standard deviation, Q Quartile, Min Minimum, Max Maximum, KW Kruskal–Wallis one-way ANOVA.
Oral health-related quality of life.
| Variables | Total (n = 1178) | Greater emotional burden compared to pre-pandemic (n = 429) | Equal emotional burden compared to pre-pandemic (n = 594) | Less emotional burden compared to pre-pandemic (n = 134) | Emotional burden compared to pre-pandemic data missing (n = 21) | p-Value |
|---|---|---|---|---|---|---|
| n | 1103 | 402 | 567 | 128 | 6 | |
| Missing | 75 (6%) | 27 (6%) | 27 (5%) | 6 (4%) | 15 (71%) | |
| Mean | 4.8 | 7.7 | 3.1 | 3.8 | 2 | |
| SD | 7.5 | 9.4 | 5.1 | 7.1 | 2.6 | |
| Median | 2 | 4 | 1 | 1.5 | 1.5 | |
| Q1–Q3 | 0–6 | 1–11 | 0–4 | 0–4 | 0–2 | |
| Min–Max | 0–53 | 0–53 | 0–37 | 0–48 | 0–7 | |
| n | 1145 | 417 | 589 | 132 | 7 | |
| Missing | 33 (3%) | 12 (3%) | 5 (1%) | 2 (1%) | 14 (67%) | |
| Mean | 0.28 | 0.37 | 0.22 | 0.27 | 0.14 | |
| SD | 0.91 | 1 | 0.79 | 1 | 0.38 | |
| Median | 0 | 0 | 0 | 0 | 0 | |
| Q1–Q3 | 0–0 | 0–0 | 0–0 | 0–0 | 0–0 | |
| Min–Max | 0–8 | 0–8 | 0–6 | 0–8 | 0–1 | |
| n | 1143 | 417 | 586 | 134 | 6 | |
| Missing | 35 (3%) | 12 (3%) | 8 (1%) | 0 (0%) | 15 (71%) | |
| Mean | 0.88 | 1.5 | 0.48 | 0.6 | 0.67 | |
| SD | 1.4 | 1.8 | 0.92 | 1.3 | 0.82 | |
| Median | 0 | 1 | 0 | 0 | 0.5 | |
| Q1–Q3 | 0–1 | 0–2 | 0–1 | 0–1 | 0–1 | |
| Min–Max | 0–8 | 0–8 | 0–8 | 0–8 | 0–2 | |
| n | 1137 | 415 | 583 | 133 | 6 | |
| Missing | 41 (3%) | 14 (3%) | 11 (2%) | 1 (1%) | 15 (71%) | |
| Mean | 1 | 1.7 | 0.6 | 0.65 | 0.5 | |
| SD | 1.5 | 1.8 | 1 | 1.2 | 0.55 | |
| Median | 0 | 1 | 0 | 0 | 0.5 | |
| Q1–Q3 | 0–2 | 0–3 | 0–1 | 0–1 | 0–1 | |
| Min–Max | 0–8 | 0–8 | 0–6 | 0–8 | 0–1 | |
| n | 1144 | 418 | 587 | 133 | 6 | |
| Missing | 34 (3%) | 11 (3%) | 7 (1%) | 1 (1%) | 15 (71%) | |
| Mean | 0.77 | 1.2 | 0.53 | 0.59 | 0.17 | |
| SD | 1.5 | 1.9 | 1.1 | 1.1 | 0.41 | |
| Median | 0 | 0 | 0 | 0 | 0 | |
| Q1–Q3 | 0–1 | 0–2 | 0–1 | 0–1 | 0–0 | |
| Min–Max | 0–8 | 0–8 | 0–6 | 0–6 | 0–1 | |
| n | 1146 | 420 | 588 | 132 | 6 | |
| Missing | 32 (3%) | 9 (2%) | 6 (1%) | 2 (1%) | 15 (71%) | |
| Mean | 0.48 | 0.79 | 0.27 | 0.47 | 0 | |
| SD | 1.2 | 1.5 | 0.81 | 1.2 | 0 | |
| Median | 0 | 0 | 0 | 0 | 0 | |
| Q1–Q3 | 0–0 | 0–1 | 0–0 | 0–0 | 0–0 | |
| Min–Max | 0–8 | 0–8 | 0–7 | 0–7 | 0–0 | |
| n | 1147 | 419 | 589 | 133 | 6 | |
| Missing | 31 (3%) | 10 (2%) | 5 (1%) | 1 (1%) | 15 (71%) | |
| Mean | 0.6 | 0.87 | 0.43 | 0.5 | 0 | |
| SD | 1.2 | 1.4 | 1 | 1.1 | 0 | |
| Median | 0 | 0 | 0 | 0 | 0 | |
| Q1–Q3 | 0–1 | 0–1 | 0–0 | 0–0 | 0–0 | |
| Min–Max | 0–8 | 0–8 | 0–7 | 0–6 | 0–0 | |
| n | 1147 | 420 | 587 | 134 | 6 | |
| Missing | 31 (3%) | 9 (2%) | 7 (1%) | 0 (0%) | 15 (71%) | |
| Mean | 0.94 | 1.5 | 0.58 | 0.81 | 0.5 | |
| SD | 1.6 | 2 | 1.2 | 1.6 | 1.2 | |
| Median | 0 | 0 | 0 | 0 | 0 | |
| Q1–Q3 | 0–1 | 0–3 | 0–1 | 0–1 | 0–0 | |
| Min–Max | 0–8 | 0–8 | 0–8 | 0–8 | 0–3 |
Significant values are in bold.
All missing values were excluded for statistical testing.
n number of participants, COVID-19 coronavirus disease 2019, OHIP Oral Health Impact Profile, SD standard deviation, Q Quartile, Min Minimum, Max Maximum, KW Kruskal–Wallis one-way ANOVA.
Stepwise linear regression result for modeling OHIP-G14 sum score with fixed effects (n = 928).
| Variable | Estimate | Lower 95% CI | Upper 95% CI | p-value |
|---|---|---|---|---|
| Intercept | − 1.625 | − 2.614 | − 0.636 | |
| PHQ-Stress sum score | 0.585 | 0.440 | 0.730 | |
| PHQ-4 sum score | 0.973 | 0.778 | 1.169 | |
| Sex: female | − 0.240 | − 1.035 | 0.555 | 0.554 |
| Age group: 40–59 years | 0.848 | − 0.059 | 1.755 | 0.067 |
| Age group: 60–100 years | 1.706 | 0.707 | 2.704 | |
| COVID-19 history: yes | 12.050 | 9.078 | 15.022 | |
| Systemic diseases: yes | 0.890 | 0.064 | 1.716 | |
| Pandemic-related restrictions in life: strong | 0.287 | − 1.134 | 1.707 | 0.692 |
| Pandemic-related restrictions in life: little | − 0.617 | − 1.817 | 0.583 | 0.313 |
Significant values are in bold.
CI confidence interval, OHIP Oral Health Impact Profile, PHQ Patient Health Questionnaire, COVID-19 coronavirus disease 2019.
Figure 1OHIP-G14 sum score stratified to participants with and without COVID-19 history (A) and greater, equal or less emotional burden compared to pre-pandemic (B).